NAV Growth

Growth of each fund's NAV over the selected period, rebased to 0%

Growth of each fund's NAV over the selected period, rebased to 0%

‌

Fund Details

Fund Details	ICICI Pru Nifty Pharma Index Fund-Dir (G)
Fund Type	Other
Risk	Very High
Min SIP Amount	₹1,000
Min Lumpsum	₹1,000
Expense Ratio	0.51%
NAV	₹22.28 (11 Nov 2026)
Fund Size	₹177.33 Cr
Fund Started	14 Dec 2022
Lock-in Period	No lock-in
Exit Load	Nil.

Returns	ICICI Pru Nifty Pharma Index Fund-Dir (G)
1M	11.26%
3M	8.78%
6M	19.99%
1Y	30.47%
3Y	23.16%
5Y	—
Since Inception	22.88%

Trailing risk-adjusted performance measures

Risk Ratio	ICICI Pru Nifty Pharma Index Fund-Dir (G)
Alpha	-0.57
Beta	1.00
Sharpe	1.02
Standard Deviation	4.53

Holding Analysis	ICICI Pru Nifty Pharma Index Fund-Dir (G)
Top 5 Holdings	55.94%
Top 10 Holdings	78.53%
Portfolio Turnover	0.30
Equity	99.90%
Debt	0.60%
Cash	—

Name	Assets
Sun Pharmaceutical ...Equity	18.60%
Divis Laboratories LtdEquity	12.28%
Laurus Labs LtdEquity	9.26%
Dr Reddys Laborator...Equity	8.15%
Cipla LtdEquity	7.67%
Torrent Pharmaceuti...Equity	6.71%
Lupin LtdEquity	4.83%
Aurobindo Pharma LtdEquity	4.59%
Glenmark Pharmaceut...Equity	3.42%
Zydus Lifesciences LtdEquity	3.05%

Fund Manager	ICICI Pru Nifty Pharma Index Fund-Dir (G)
Name	, ,

About	ICICI Pru Nifty Pharma Index Fund-Dir (G)
AMC	ICICI Prudential Mutual Fund
Scheme Category	Index Fund
Benchmark	Nifty Pharma TRI
Launch Date	25 Nov 2022